K. D. Bagshawe

Medicine · Health Sciences

47h-index8.0kcitations214works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gestational Trophoblastic Disease Studies(81), Monoclonal and Polyclonal Antibodies Research(31), Prenatal Screening and Diagnostics(26), Testicular diseases and treatments(26), Ovarian cancer diagnosis and treatment(15)

Publications214 total

Macrophage Electrophoretic Mobility and Structuredness of Cytoplasmic Matrix
Antibiotics and chemotherapy/Antibiotica et chemotherapia·2015· 2 cited
Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years
European Journal of Cancer·1998· 84 cited
Management of resistant gestational trophoblastic tumors.
PubMed·1998· 39 cited
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Journal of Clinical Oncology·1997· 309 cited
Gestational Trophoblastic Disease With Liver Metastases
Obstetrical & Gynecological Survey·1997
Effect of cyclosporine on immunogenicity of a bacterial enzyme carboxypeptidase G2 in ADEPT.
PubMed·1996· 8 cited
Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT.
PubMed·1996· 32 cited
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors.
Journal of Clinical Oncology·1996· 184 cited
Placental site trophoblastic tumor: molecular analysis and clinical experience.
PubMed·1996· 53 cited
A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non‐molar hydropic abortions
Histopathology·1996· 162 cited
1169 Placental site trophoblastic tumours at charing cross 1975–1995
European Journal of Cancer·1995
Antibody directed enzyme prodrug therapy (ADEPT)
Annals of Oncology·1994· 97 citedOpen Access
Antibody-Directed Enzyme Prodrug Therapy
Clinical Pharmacokinetics·1994· 54 cited
The long‐term outcome of patients who relapse after chemotherapy for non‐seminomatous germ cell tumours
British Journal of Urology·1994· 14 cited
Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical study
Cell Biophysics·1994· 11 cited
Antibody-directed enzyme prodrug therapy (Adept)
Journal of Controlled Release·1994· 17 cited
Serological Tumour Markers: An Introduction
Medical Entomology and Zoology·1993· 4 cited
Antitumor effects of an antibody-carboxypeptidase g2 conjugate in combination with a benzoic acid mustard prodrug
Cell Biophysics·1993· 21 cited
Identification of prodrug, active drug, and metabolites in an ADEPT clinical study
Cell Biophysics·1993· 26 cited
Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2
Journal of Immunological Methods·1993· 45 cited
page 1 of 11Next →

Frequent Co-authors

E.S. Newlands(13), Gordon Rustin(11), Richard H. J. Beǵent(9), G A Currie(7), J. Dent(7), L. Holden(6), F.J. Paradinas(5), C E Wilde(4), Mark Bower(3), D Short(3), G.J.S. Rustin(3), Marianne Foskett(3), G.T. Rogers(3), A. HILARY ORR(3), Rosemary A. Fisher(2), Michael E. Stone(2), A Kardana(2), P A M Walden(2), Roger G. Melton(2), R. N. HITCHINS(2)